AlphaYouPHIO: Bitterman Robert J discloses a purchase
By AlphaYouPublished Form 4
Bitterman Robert J
Reporting filer
Bitterman Robert J reported Purchase in Phio Pharmaceuticals Corp.: 2000 units of Common Stock, $.0001 par value, dated 2026-09-22. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value | Bitterman Robert J | 2026-09-22 | P | Purchase | 2000 | 1.0289 | 364,871 | 1 day | Filed terms
|
Common Stock, $.0001 par value
- Owner
- Bitterman Robert J
- Date
- 2026-09-22
- Code
- P
- Action
- Purchase
- Quantity
- 2000
- Price
- 1.0289
- Following holdings
- 364,871
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock, $.0001 par value
- transaction Date: 2026-09-22
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 2000
- transaction Price Per Share: 1.0289
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 364871
- id: F1
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bitterman Robert J: Chairman, Pres. & CEO, Director.
- F1: Includes shares of common stock underlying unvested restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.